{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:33:44Z","timestamp":1790728424943,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T00:00:00Z","timestamp":1510012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Major Research Program of National Natural Science Foundation of China","award":["91542108"],"award-info":[{"award-number":["91542108"]}]},{"name":"Major Research Program of National Natural Science Foundation of China","award":["81471513"],"award-info":[{"award-number":["81471513"]}]},{"name":"Major Research Program of National Natural Science Foundation of China","award":["31671200"],"award-info":[{"award-number":["31671200"]}]},{"name":"Major Research Program of National Natural Science Foundation of China","award":["81671460"],"award-info":[{"award-number":["81671460"]}]},{"name":"Major Research Program of National Natural Science Foundation of China","award":["31600735"],"award-info":[{"award-number":["31600735"]}]},{"name":"Major Research Program of National Natural Science Foundation of China","award":["81601354"],"award-info":[{"award-number":["81601354"]}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"crossref","award":["16QA1400800"],"award-info":[{"award-number":["16QA1400800"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Development Fund of Shanghai Talents","award":["201557"],"award-info":[{"award-number":["201557"]}]},{"name":"Oriented Project of Science and Technology Innovation from Key Lab. of Reproduction Regulation of NPFPC","award":["CX2017-2"],"award-info":[{"award-number":["CX2017-2"]}]},{"name":"Program for Zhuoxue of Fudan University"},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"publisher","award":["17ZR1403200"],"award-info":[{"award-number":["17ZR1403200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.neo.2017.11.003","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T15:36:37Z","timestamp":1512142597000},"page":"69-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27\u2013Stimulated Cytotoxicity of NK Cells"],"prefix":"10.1016","volume":"20","author":[{"given":"Wen-Jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2017.11.003_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10787-017-0336-1","article-title":"Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases","volume":"25","author":"Kaur","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neo.2017.11.003_bb0010","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2014.58.8871","article-title":"Randomized phase II trial of ridaforolimus in advanced endometrial carcinoma","volume":"33","author":"Oza","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2017.11.003_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2014.06.033","article-title":"Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer","volume":"135","author":"Tsoref","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.neo.2017.11.003_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2016-08-734020","article-title":"GVHD prevents NK-cell\u2013dependent leukemia and virus-specific innate immunity","volume":"129","author":"Bunting","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.neo.2017.11.003_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0030","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/ajt.12351","article-title":"Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic type 1 polarization modulated by NK cells","volume":"13","author":"Macedo","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.neo.2017.11.003_bb0035","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/cncr.24431","article-title":"Synergistic effect of rapamycin and cisplatin in endometrial cancer cells","volume":"115","author":"Bae-Jump","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2276","article-title":"Evolutionary struggles between NK cells and viruses","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0952-7915(00)00198-9","article-title":"Recognition of tumor cells by the innate immune system","volume":"13","author":"Soloski","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1535-6108(02)00095-8","article-title":"Epigenetic changes in tumor Fas levels determine immune escape and response to therapy","volume":"2","author":"Maecker","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2017.11.003_bb0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.184.2.579","article-title":"Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism","volume":"184","author":"Zheng","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.neo.2017.11.003_bb0060","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","article-title":"Prognostic value of intratumoral natural killer cells in gastric carcinoma","volume":"88","author":"Ishigami","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(01)00292-6","article-title":"Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer","volume":"35","author":"Villegas","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2017.11.003_bb0080","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4049\/jimmunol.172.4.2225","article-title":"WSX-1and glycoprotein 130 constitute a signal-transducing receptor for IL-27","volume":"172","author":"Pflanz","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0085","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2012.11.003","article-title":"Interleukin-27: balancing protective and pathological immunity","volume":"37","author":"Hunter","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2017.11.003_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2012.12.002","article-title":"IL-27 in tumor immunity and immunotherapy","volume":"19","author":"Murugaiyan","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neo.2017.11.003_bb0095","doi-asserted-by":"crossref","first-page":"e2666","DOI":"10.1038\/cddis.2017.95","article-title":"IL-27 triggers IL-10 production in Th17 cells via a c-Maf\/ROR\u03b3t\/Blimp-1 signal to promote the progression of endometriosis","volume":"8","author":"Chang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neo.2017.11.003_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1476-4598-12-171","article-title":"Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms","volume":"12","author":"Kumar","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells5020024","article-title":"Advances in Autophagy Regulatory Mechanisms","volume":"5","author":"Gallagher","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neo.2017.11.003_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmed.2009.01.002","article-title":"When apoptosis meets autophagy: deciding cell fate after trauma and sepsis","volume":"15","author":"Hsieh","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neo.2017.11.003_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.neo.2017.11.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2017.1362525","article-title":"Autophagy dictates metabolism and differentiation of inflammatory immune cells","author":"Riffelmacher","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.neo.2017.11.003_bb0125","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neo.2017.11.003_bb0130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/cdd.2009.54","article-title":"The late stages of autophagy: how does the end begin?","volume":"16","author":"Noda","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neo.2017.11.003_bb0135","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/MCB.16.6.2857","article-title":"Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase","volume":"16","author":"Mendez","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neo.2017.11.003_bb0140","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","article-title":"Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells","volume":"270","author":"Sabers","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2017.11.003_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/377441a0","article-title":"Control of p70, s6 kinase by kinase activity of FRAP in vivo","volume":"377","author":"Brown","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neo.2017.11.003_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.277.5322.99","article-title":"Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin","volume":"277","author":"Brunn","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neo.2017.11.003_bb0165","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1158\/0008-5472.CAN-04-0807","article-title":"Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells","volume":"64","author":"Agbunag","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2017.11.003_bb0170","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1158\/0008-5472.CAN-04-4420","article-title":"Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras","volume":"65","author":"Wislez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2017.11.003_bb0175","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.neo.2017.11.003_bb0180","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1182\/blood.V100.3.1084","article-title":"Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells","volume":"100","author":"Hackstein","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.neo.2017.11.003_bb0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/eji.201444699","article-title":"IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness","volume":"45","author":"Ziblat","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0190","doi-asserted-by":"crossref","first-page":"21315","DOI":"10.18632\/oncotarget.7040","article-title":"Metformin inhibits 17\u03b2-estradiol-induced epithelial-to-mesenchymal transition via \u03b2Klotho-related ERK1\/2 signaling and AMPK\u03b1 signaling in endometrial adenocarcinoma cells","volume":"27","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2017.11.003_bb0195","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.4049\/jimmunol.180.10.6527","article-title":"Antiproliferative activity of IL-27 on melanoma","volume":"180","author":"Yoshimoto","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0200","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.4049\/jimmunol.176.12.7317","article-title":"Antiangiogenic and antitumor activities of IL-27","volume":"176","author":"Shimizu","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0205","doi-asserted-by":"crossref","first-page":"e12706","DOI":"10.1111\/aji.12706","article-title":"The cross talk between cervical carcinoma cells and vascular endothelial cells mediated by IL-27 restrains angiogenesis","volume":"78","author":"Zhang","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0210","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/0008-5472.CAN-03-2084","article-title":"Potent antitumor activity of interleukin-27","volume":"64","author":"Hisada","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2017.11.003_bb0215","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.4049\/jimmunol.173.12.7170","article-title":"IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells","volume":"173","author":"Salcedo","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.neo.2017.11.003_bb0220","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/ijc.24107","article-title":"Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity","volume":"124","author":"Shinozaki","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","author":"Levy","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2017.11.003_bb0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/15548627.2016.1239676","article-title":"GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.neo.2017.11.003_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/15548627.2016.1269990","article-title":"PRKCD\/PKC\u03b4 contributes to nephrotoxicity during cisplatin chemotherapy by suppressing autophagy","volume":"13","author":"Zhang","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.neo.2017.11.003_bb0240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biocel.2014.08.022","article-title":"IL-27 inhibits IFN-\u03b3 induced autophagy by concomitant induction of JAK\/PI3 K\/Akt\/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages","volume":"55","author":"Sharma","year":"2014","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558617304396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558617304396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T10:54:09Z","timestamp":1603450449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558617304396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1476558617304396"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2017.11.003","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27\u2013Stimulated Cytotoxicity of NK Cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2017.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}